Abaxis Inc  

(Public, NASDAQ:ABAX)   Watch this stock  
Find more results for ABAX
51.17
-0.91 (-1.75%)
Jun 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 51.10 - 52.41
52 week 41.57 - 66.89
Open 51.95
Vol / Avg. 87,020.00/155,344.00
Mkt cap 1.18B
P/E 58.60
Div/yield 0.11/0.86
EPS 0.87
Shares 22.67M
Beta 0.74
Inst. own 108%
Jul 22, 2015
Q1 2016 Abaxis Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 4, 2015
Abaxis Inc at Jefferies Global Healthcare Conference
May 27, 2015
Abaxis Inc at Stifel Dental & Veterinary Conference
May 12, 2015
Abaxis Inc at Bank of America Merrill Lynch Health Care Conference
Apr 30, 2015
Q4 2015 Abaxis Inc Earnings Call - Webcast
Apr 30, 2015
Q4 2015 Abaxis Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2015
Net profit margin 7.31% 10.27%
Operating margin 13.79% 16.93%
EBITD margin - 21.12%
Return on average assets 5.92% 8.55%
Return on average equity 7.12% 10.05%
Employees 582 -
CDP Score - -

Address

3240 Whipple Rd
UNION CITY, CA 94587-1217
United States - Map
+1-510-6756500 (Phone)
+1-510-4416150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells portable blood analysis systems that are used in a range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. The Company provides veterinary reference laboratory diagnostic and consulting services for veterinarians. The Company operates in two segments, including the medical market and the veterinary market. The medical market and the veterinary market are based on the diagnostic products sold and services provided by market and customer group. The Company’s product and service offerings include VetScan Point-of-Care Blood Chemistry Instruments, VetScan Profiles, VSpro Specialty Analyzers and Consumables, and i-STAT Instruments and Consumables. Abaxis Europe GmbH, the Company’s wholly owned subsidiary in Griesheim, Germany, markets, promotes and distributes diagnostic systems for medical and veterinary uses in the European market.

Officers and directors

Clinton H. Severson Chairman of the Board, Chief Executive Officer
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald Peter Wood President, Chief Operating Officer
Age: 62
Bio & Compensation  - Reuters
Alberto R. Santa Ines Chief Financial Officer, Vice President - Finance
Age: 67
Bio & Compensation  - Reuters
Kenneth P. Aron Ph.D. Chief Technology Officer
Age: 61
Bio & Compensation  - Reuters
Ross Taylor Chief Financial Officer, Secretary
Bio & Compensation  - Reuters
Craig M. Tockman Vice President, Sales & Marketing – NAAH
Age: 54
Bio & Compensation  - Reuters
Achim Henkel Vice President - Marketing for Pacific Rim, Vice President - Government Affairs, Managing Director of Abaxis Europe GmbH
Age: 56
Bio & Compensation  - Reuters
Vernon Edward Altman Independent Director
Age: 67
Bio & Compensation  - Reuters
Richard J. Bastiani Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters
Michael D. Casey Independent Director
Age: 69
Bio & Compensation  - Reuters